| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |